Dr. Ryan Scott Jackson, MD

Dr. Jackson practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Jackson's NPI, 1710114582, was assigned on June 18, 2009. Dr. Jackson graduated from St. Louis College of Physicians and Surgeons in 2009. Dr. Jackson holds Missouri license 2015010898.

Dr. Jackson's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Jackson also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Jackson's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Jackson is also affiliated with Barnes-Jewish West County Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Jackson to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jackson practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Jackson's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Jackson is licensed in Missouri.

CMS data shows 471 Medicare services from Dr. Jackson across 9 procedure codes in 2024, for 276 Medicare patients. Medicare paid $63,033 for them.

CMS counts 276 Medicare patients who saw Dr. Jackson in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jackson's median patient age at 71, with 38% women.

In 2024, Dr. Jackson wrote 160 Medicare Part D claims for 65 patients. 96% of them were for generic drugs. CMS names the drug for 81 of them, across 5 drugs with 11 or more claims each, at $705 in total drug cost. In 2023, CMS named 185 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Jackson for performance year 2024, reported as part of a group. Dr. Jackson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 124 papers to Dr. Jackson, published from 2013 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Oropharyngeal Neoplasms. Dr. Jackson has published most often in Otolaryngol Head Neck Surg. Dr. Jackson's most frequent co-authors are Patrik Pipkorn, MD, Jason Thomas Rich, MD and Wade Larry Thorstad, MD.

Dmand AI links Dr. Jackson to 7 clinical trials, 4 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell and Head and Neck Neoplasms. Washington University School of Medicine sponsors the most, 6.

CMS Open Payments shows 354 general payments to Dr. Jackson from 16 drug and device companies from 2016 to 2025. Education make up the largest share, 80% of the total. Intuitive Surgical, Inc. paid the most, $291,198.

Dr. Jackson graduated from St. Louis College of Physicians and Surgeons in 2009.